NIH-funded research U01 cooperative agreement

AI-powered portable colposcopy device to guide cervical cancer screening

Official title: Development and Validation of an Artificial-Intelligence-enabled Portable Colposcopy Device for Optimizing Triage Alternatives for HPV-based Cervical Cancer Screening

Funded at Duke University · NIH-11416400 · Data updated 2026-11-12

A portable, AI-assisted device aims to triage HPV-positive women in low-resource settings to quickly and accurately identify who needs treatment.

More Cervical Cancer Screening research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startMay 20, 2022
Project endApril 30, 2027
Funding year2026
Award (this year)$1,031,758
NIH project number5U01CA269192-05
Project IDNIH-11416400 on NIH RePORTER

Who could benefit from this research

Could help

Individuals undergoing HPV-based cervical cancer screening in low-resource settings who could benefit from a portable triage tool.

Less likely to help

Patients in settings with ready access to standard colposcopy and pathology may see limited added value.

What this research studies

This project develops a low-cost imaging device for the cervix combined with an automated machine-learning diagnosis to support single-visit cervical cancer screening in areas with limited health infrastructure. It targets settings where cytology and specialist pathology are scarce, aiming to reduce follow-up losses and unnecessary referrals. The approach emphasizes a user-friendly tool that can be used with minimal trained staff to help make rapid, accurate triage decisions. The work involves validating the AI system against standard diagnostic methods and testing its performance in real-world, resource-limited environments.

Why it matters

Potential benefit: If successful, the device could enable timely, accurate triage and treatment decisions, potentially reducing cervical cancer deaths in underserved communities.

How similar studies have gone: Prior studies show promise for AI-assisted imaging tools in cervical cancer screening, but real-world deployment in low-resource settings remains challenging and ongoing.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Ramanujam, Nirmala — Duke University
  • Study coordinator: Ramanujam, Nirmala

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.